MEDELIOS

Active

Private limited companyfounded 2024active for 1 yearAvenue de la Closière 12, 1410 Waterloo, BelgiumKBO/BCE: BE 1016.259.892

Summary

MEDELIOS has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €267,953 and a net result of €212,587. Its solvency ranks better than 69% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

MEDELIOSActiveChecked score 98/100

Risk analysis Report Compare

Activity

General medical practice

NACE 86210

1 site

Size

€339,194total assets 2025

Equity: €267,953
Profit: €212,587

Turnover not published (micro format)

Financial health

98 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

DAOUD Mathieu Gaby VictorDirector
MÉNEZ OphélieDirector

2025 accounts filed 26 days late

Why 98raises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.71, cash €212,593Equity €267,953 (79.0% of total assets)Show the evidence

Checked score

Score 2025

98 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 85% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 79.0% of total assets

Liquidity 93+2

short-term debt 21.0% · cash 62.7%

Profitability 100=

return on assets 62.7%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,112 companies, NACE 86, micro)

Last 24 months 12-2025: < 0.1% 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026highest value 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €25,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record

Liquidity ample (current ratio 4.71, compared with 4.07 in 2024, above the usual 1.5; short-term debt: 21% and cash: 62.7% of total assets), and 21% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 79% on liquidity, 80% on profitability and 97% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises risk

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 4.71, cash €212,593

NBB · annual accounts

1 change of registered office in 24 months

Belgian Official Gazette

Equity €267,953 (79.0% of total assets)

NBB · annual accounts

Young company

Founded in 2024, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.

KBO · incorporation date

Age against the risk zone

2025 accounts filed 26 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 2 filings

Deviation from the deadline

2025

26 days late

2024

17 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 5 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Where today falls in the filing period

24-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since incorporation in 2024.

KBO publications · our coverage

26-08-2026 Annual accounts filedfinancial year 2025 · micro…
31-12-2025 Equity above €200,000equity €267,953 ▲384%
04-09-2025 Registered officeShareholding · Registered-office move ·…

Key points

Positive: Result rose in 2025from €51,866 to €212,587 ▲ 310% View
Positive: Among the best 11% on net resultsector median €60,170 · 20,585 companies €212,587 View
Board2 directors in office 2 View

By topic

Financials

Financial year: 2025
Total assets: €339,194
Profit: €212,587
Solvency: 79.0%

Total assets▲ 362%

Net result

20242025

Go to Financials

Board & ownership

Board: 2 members

DAOUD Mathieu Gaby VictorDirector
MÉNEZ OphélieDirector

Go to Board & ownership

Timeline

Events: 5
Since: 2024
Next accounts: by 31-07-2027

14-07-2025Annual accounts filed
19-11-2024Incorporation

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: General medical practiceNACE 86210
Founded: 15-11-2024
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 26

Statutory auditor: No statutory auditor

Go to Articles of association

Key facts about MEDELIOS

What is the company number of MEDELIOS?: 1016.259.892. In Belgium the VAT number is the company number with BE in front: BE 1016.259.892.
Where is MEDELIOS based?: The registered office is at Avenue de la Closière 12, 1410 Waterloo.Company details
What does MEDELIOS do?: According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of MEDELIOS?: Private limited company (BV).
When was MEDELIOS founded?: On 15-11-2024.
Is MEDELIOS still active?: Yes, MEDELIOS is an active enterprise in the KBO register.
What is the turnover of MEDELIOS?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is MEDELIOS profitable?: In financial year 2025, MEDELIOS made a profit of €212,587.
Where can I find the annual accounts of MEDELIOS?: MEDELIOS filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDELIOS due?: By 31-07-2027, for financial year 2026.Timeline